DSP Clinical Research

VetPharm, Inc. is a full-service contract research organization (CRO) dedicated exclusively to animal health. It offers a complete menu of pilot/pivotal/post-marketing clinical trial support services, including protocol development, data form design, investigator recruitment, site qualification, enrollment enhancement, study administration, ICH-GCP training, site monitoring, data management, statistical analysis, medical writing, and regulatory support to pharmaceutical, biotechnical, nutraceutical, nutrition, and device companies in the United States and Europe. VetPharm employs a comprehensive study management system and a consortium of study-ready investigators which facilitate rapid study initiation, accelerated enrollment, and superior results to meet sponsors'​ critical timelines.

VetPharm has broad clinical trial experience across all therapeutic areas which enables it to undertake virtually any trial and complete it quickly, efficiently, and accurately. VetPharm's investigator consortium includes board-certified specialists in the following disciplines: Behavior, Cardiology, Dentistry, Dermatology, Endocrinology, Gastroenterology, Immunology, Internal Medicine, Neurology, Oncology, Ophthalmology, Radiology, Surgery, Theriogenology, and Urology.

Athena Diagnostics is a clinical diagnostics service testing laboratory focused on neurology, endocrinology and nephrology. As a leader in genetic testing and personalized medicine, Athena's mission is to improve the lives of patients by providing the best possible diagnostic services to their physicians. Started as Genica Pharmaceuticals in 1988, Athena Diagnostics has undergone several changes of control: acquired by Athena Neuroscience in 1995, acquired by Elan Pharmaceuticals in 1996, acquired by Behrman Capital in 2002, acquired in 2006 by Fisher Scientific, which became Thermo Fisher, and acquired by Quest Diagnostics in 2011. Athena has over 300 diagnostic tests, 300 employees and 2010 revenues of $110 million.

Mission
Diablo Clinical Research is committed to advancing health through medical research and community service.



History
Diablo Clinical Research, established by Dr. Weinstein in 1995, has conducted over 600 studies with thousands of patients. Today our database is comprised of over 12,000 patients who have either completed a study with us, are currently enrolled in a study, or have expressed interest in future clinical study participation.

Our Founder and Medical Director Richard L. Weinstein, MD a board certified endocrinologist and internist has practiced medicine in the San Francisco Bay Area for 30 years.

In 2005 Leonard Chuck, PhD, MD and a practicing internist in our local community for over 20 years joined Diablo Clinical Research as an Investigator. In 2007 Mark Christiansen, MD, who practiced and conducted research in the community for over 17 years, also joined Diablo Clinical Research as an Investigator. Both Dr. Chuck and Dr. Christiansen became Co-Medical Directors of our facility in 2008.

Diablo Clinical Research specializes in clinical research. We have been working in our Walnut Creek location for over 17 years. We have 6 MDs on staff with specialties in endocrinology, internal medicine, cardiology, and neurology.

Amarex is a global, full-service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs (FDA Applications and meetings, Applications to International Health Authorities, GxP Compliance Audits), Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management, Medical Monitoring, Safety and Pharmacovigilance, and General Consulting. Amarex can take your product through the entire approval process, from creating the regulatory approval strategy, to conducting trials, to writing the marketing approval application. Join our growing list of clients with approved products. Amarex provides high quality and cost efficient services.

Sign-up to receive invites to webinars, training courses and the latest cutting-edge information on clinical trials: https://go.pardot.com/l/129231/2020-07-27/39ng9k

DP Clinical, Inc. is a privately held Contract Research Organization (CRO) specializing in neurology/CNS (including spinal cord injury), oncology, ophthalmology, infectious disease/vaccines, and rare disease Phase I-IV clinical programs. DP Clinical provides a full complement of clinical trial services to pharmaceutical, biotech, and medical device companies including trial management, monitoring, data management, biostatistics, regulatory, safety monitoring and reporting, and medical writing. Since 1994, we have worked for clients of all sizes — small to large pharmaceutical and biotech companies, academic research institutions, and government sponsors.

DP Clinical provides integrated trial solutions as well as specific service components based on sponsor need. Our comprehensive services include:
• Project management
• Clinical trial monitoring
• Data management
• Biostatistics
• Pharmacovigilance and safety
• Regulatory affairs
• Quality assurance
• Medical writing